Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B

Clin Infect Dis. 2002 Nov 1;35(9):1135-6. doi: 10.1086/343748.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adult
  • Amphotericin B / administration & dosage
  • Amphotericin B / pharmacology*
  • Anti-Bacterial Agents / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Candida / drug effects
  • Candidiasis / drug therapy*
  • Caspofungin
  • Drug Delivery Systems
  • Drug Resistance, Fungal
  • Echinocandins
  • Humans
  • Lipopeptides
  • Liposomes
  • Male
  • Peptides*
  • Peptides, Cyclic*
  • Spleen / microbiology*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Liposomes
  • Peptides
  • Peptides, Cyclic
  • Amphotericin B
  • Caspofungin